BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

  March 23, 2026

   · 

  8 min read
• Press Releases

  Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

  March 23, 2026

   · 

  4 min read
• Press Releases

  Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business

  March 23, 2026

   · 

  6 min read
• Press Releases

  Integrated DNA Technologies Expands into Clinical Diagnostics with First In Vitro Diagnostic

  March 23, 2026

   · 

  3 min read
• Press Releases

  Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

  March 23, 2026

   · 

  5 min read
• Press Releases

  Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review

  March 23, 2026

   · 

  7 min read
• 

  Funding

  Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design

  Earendil Labs’ AI-centered platform has produced more than 40 programs, including anti-inflammatory assets that have attracted a pair of partnership agreements with Sanofi.

  March 23, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Parkinson’s disease

  FDA Warns of Seizure Risk With Some Parkinson’s Drugs

  The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking carbidopa/levodopa drugs. Both AbbVie and Novartis market levodopa-based products.

  March 23, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

  March 23, 2026

   · 

  15 min read
• Press Releases

  BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions

  March 23, 2026

   · 

  2 min read